Most Active Growth / Late Stage Investors in Europe

What is a Growth / Late Stage round?

A Growth or Late Stage round — typically referred to as Series C and beyond, though some frameworks include late Series B — represents a funding event where a startup has already demonstrated repeatable, scalable business mechanics and is raising capital primarily to accelerate what is already working. By this point, the company has moved well past the question of product-market fit and is focused on market capture, geographic expansion, or preparation for a liquidity event such as an IPO or strategic acquisition.

This stage sits between the earlier venture rounds (Seed through Series B), which are primarily about de-risking the business model, and the pre-IPO or public market phase. What distinguishes Growth and Late Stage rounds from earlier financing is the emphasis on metrics-driven underwriting. Investors at this stage are evaluating the efficiency and predictability of the business — unit economics, net revenue retention, payback periods, and market share trajectory — rather than making bets on team or vision alone.

Round sizes at this stage are materially larger, and the investor composition shifts significantly. Earlier rounds are dominated by traditional venture capital firms willing to absorb high uncertainty. Growth and Late Stage rounds attract growth equity funds, crossover investors, sovereign wealth funds, and in some cases private equity firms that apply a more structured, returns-oriented framework.

In the European context, this stage has matured considerably over the past decade. A growing number of European-headquartered growth funds now compete with US and Asian investors for the region's breakout companies, reducing the historical dependency on transatlantic capital that characterized European late-stage deals in earlier cycles. The stage is also increasingly bifurcated between capital-efficient software businesses and capital-intensive sectors like fintech infrastructure, climate tech, and deep tech.

What are the goals of Growth / Late Stage funding?

At the Growth and Late Stage, capital is deployed against a very different set of priorities than in earlier rounds. Founders are not using this money to find product-market fit or build foundational engineering capacity — they are using it to scale systems, markets, and teams that have already proven their value.

Geographic expansion is one of the most common uses of late-stage capital in Europe. A company that has achieved strong product-market fit in one or two European markets will often raise a Growth round specifically to fund the cost of entering additional countries — localizing the product, hiring local go-to-market teams, navigating regulatory environments, and building brand awareness in new regions. For European companies eyeing the US market, this expansion is particularly capital-intensive.

Sales and marketing scale-up is another primary use of funds. At this stage, companies typically have a proven customer acquisition model and are investing to apply it at significantly greater volume. This includes building out enterprise sales teams, investing in demand generation infrastructure, and in some cases funding partnerships or channel development.

Product and platform investment also features at this stage, particularly for companies whose competitive moat depends on continued product depth. This might include building adjacent product lines, acquiring technology capabilities, or investing in enterprise-grade compliance and security features required for larger customers.

Operational infrastructure — finance, legal, HR, and compliance functions — is frequently underdeveloped at Series A or B stage companies and often needs significant investment to support the scale the business is targeting. Investors at this stage expect founders to be building an organization capable of operating at much greater complexity.

In some cases, secondary transactions are built into late-stage rounds, allowing early employees or investors to achieve partial liquidity, which can be an important retention and cap table management tool.

Is my startup ready to raise a Growth / Late Stage round?

Investors deploying capital at the Growth and Late Stage apply a substantially higher bar than at earlier rounds, and founders need to be able to demonstrate a set of signals that together indicate the business is genuinely ready to scale rather than simply growing.

On the revenue side, the clearest signal is consistent, compounding revenue growth at meaningful absolute scale. For software businesses, this typically means annual recurring revenue in the range of tens of millions of euros, with strong net revenue retention — often above 110 to 120 percent for B2B SaaS — indicating that the existing customer base is expanding. For transactional or marketplace businesses, gross merchandise volume, take rate, and cohort retention are equivalent indicators.

Unit economics must be demonstrably sound. Investors will scrutinize customer acquisition cost, lifetime value, payback period, and gross margins carefully. A business that is growing quickly but with deteriorating unit economics will struggle to attract quality growth investors, particularly in the more conservative capital environment that has characterized Europe in recent cycles.

Market position is equally important. Founders should be able to articulate a credible path to leadership in a large and well-defined market, and ideally show signs that the company is already building durable competitive advantages — whether through network effects, proprietary data, switching costs, or brand.

The team signal at this stage is less about the founding team's vision and more about whether the organization has the management depth to operate at scale. Investors will look for experienced functional leaders in sales, finance, product, and operations, as well as evidence of a culture capable of absorbing rapid headcount growth.

A clean cap table, well-managed existing investor relationships, and absence of significant legal or regulatory exposure are table-stakes requirements that become more prominent at this stage.

What is the typical size of a Growth / Late Stage round?

Growth and Late Stage rounds in Europe span a wide range, but a useful working range is approximately €30 million at the lower end of Series C to several hundred million euros for the largest pre-IPO rounds. The most common Growth round for a European company at Series C falls somewhere between €40 million and €150 million, while Series D and later rounds frequently exceed €150 million and can reach into the billions for the continent's most capital-intensive businesses.

Sector has a significant influence on round size. Capital-intensive verticals such as fintech, climate tech, mobility, and biotech tend to command larger rounds at equivalent stages because their paths to revenue scale or regulatory approval require more sustained investment. Pure software businesses, particularly those with efficient go-to-market models, may raise smaller Growth rounds while still representing strong risk-adjusted opportunities for investors.

Geography also shapes round size considerably within Europe. The UK, and London in particular, has historically been the venue for the continent's largest late-stage rounds, partly because of the concentration of institutional and crossover capital, and partly because of the depth of the talent pool and exit market. DACH and Nordic companies have also consistently closed large Growth rounds, while Southern and Eastern European companies, though increasingly active, have generally raised at smaller sizes due to the earlier development of local growth ecosystems.

Compared to adjacent stages, Growth rounds are typically five to ten times larger than a typical Series B, reflecting both the greater capital requirements and the reduced binary risk. The compression of valuations that occurred across European markets in 2022 and 2023 brought round sizes down from peak 2021 levels, but deal activity and round sizes have gradually recovered, and the structural availability of European growth capital is considerably deeper today than it was a decade ago.

Different types of Growth / Late Stage investors

How to create a fundraising strategy for a Growth / Late Stage round

Running a Growth or Late Stage fundraising process requires significantly more preparation and process discipline than earlier rounds. The stakes are higher, the due diligence is deeper, and the investor base is more analytical. Founders who treat this like a Series A process — running it informally or sequentially — typically achieve worse outcomes.

Preparation should begin six to nine months before the intended close. This means ensuring the company's financial reporting is institutional-grade, the data room is comprehensive, and the metrics story is clean and defensible. Investors at this stage will conduct detailed commercial due diligence, reference calls with customers and partners, and technical or product audits. Any material that cannot withstand scrutiny will surface and complicate the process.

Positioning is critical. Founders should develop a clear narrative around why this is the right moment to raise, what the capital will specifically enable, and why the company is on a path to a defensible market leadership position. The narrative must be grounded in data but also forward-looking enough to justify the valuation expectation.

On sequencing, most experienced advisors recommend identifying a short list of high-conviction lead candidates — typically three to six funds — and engaging them in parallel rather than sequentially. Running a competitive process is important for maintaining leverage on valuation and terms, but the investor base at this stage is smaller and more networked than at Series A, which means news of a fundraise travels quickly.

Timeline expectations should be realistic. A Growth round with full institutional due diligence commonly takes four to six months from first meeting to close. Founders who underestimate this run the risk of creating a cash position that forces them to accept unfavorable terms.

Advisors and investment banks play a larger role at this stage than in earlier rounds. Engaging a reputable advisor can meaningfully expand the investor universe, manage process logistics, and provide market intelligence on valuation benchmarks.

What terms and dilution should I expect at Growth / Late Stage?

Growth and Late Stage rounds in Europe are almost exclusively structured as priced equity rounds — SAFEs and convertible notes, which are common at pre-seed and seed, are essentially absent at this stage. The complexity of the cap table, the institutional nature of the investors, and the size of the round all require a fully negotiated equity transaction with a defined pre-money valuation.

The standard instrument is a preferred share issuance, with terms negotiated via a shareholders' agreement and articles of association amendment. Key economic terms include the pre-money valuation, the option pool top-up, liquidation preferences, anti-dilution protections, and any participation rights. Governance terms — board composition, investor consent rights, information rights, drag-along and tag-along provisions — become increasingly important as more institutional investors join the cap table.

Liquidation preferences at Growth Stage are typically one-times non-participating preferred, meaning investors receive their investment back before common shareholders in a downside exit, but do not additionally participate in the remaining proceeds. More aggressive terms such as participating preferred or multiple liquidation preferences are less common in European growth deals than in certain US markets but can emerge in down rounds or deals with significant investor leverage.

Founder dilution at Growth Stage typically ranges from approximately 10 to 20 percent per round, depending on the size of the raise relative to the company's valuation and whether an option pool expansion is required. Cumulative dilution by the time a company reaches Series C or D means founding teams commonly retain somewhere between 30 and 50 percent of the equity, though this varies widely based on how many rounds have been raised and at what valuations.

Secondary components — allowing existing shareholders to sell a portion of their stake alongside the primary raise — are increasingly common in European Growth rounds, particularly for companies with long paths to liquidity.

Common mistakes founders make raising at Growth / Late Stage

One of the most consistent mistakes at the Growth Stage is raising too early — before the unit economics are clearly positive and scalable. Founders who have strong top-line growth but haven't yet demonstrated efficient customer acquisition or healthy gross margins will find that institutional growth investors apply a very different standard than earlier-stage VCs, and a fundraising process launched prematurely can result in a damaged narrative that follows the company into subsequent attempts.

Overvaluing the business based on peak-cycle comps is another frequent error. Many founders anchor their valuation expectations to the high-water marks of 2020 and 2021, which reflected an anomalous interest rate and sentiment environment. Institutional growth investors today are applying revenue multiples grounded in public market benchmarks, and founders who go to market with unrealistic expectations often end up in extended, damaging processes or are forced to take down rounds.

Neglecting governance preparation is a structural mistake. Companies entering their first institutional growth round often have informal governance arrangements that are poorly documented. Investors conducting due diligence at this stage will surface cap table issues, missing board resolutions, poorly structured option plans, and undefined consent rights — all of which create delay and can erode investor confidence.

Running too narrow a process — approaching only one or two investors — reduces competitive tension and gives investors disproportionate leverage on terms. Conversely, running too broad a process signals indiscrimination and can waste significant management time during a period when operating focus is critical.

Founders also frequently underestimate how much management bandwidth a Growth round consumes. Senior leaders across finance, legal, and commercial functions will be deeply involved in due diligence for weeks. Not planning for this operationally can cause performance to slip at exactly the moment investors are watching most closely.

How does Growth / Late Stage funding differ across Europe?

The European Growth and Late Stage landscape is not homogeneous, and the fundraising experience varies materially across the continent's major startup hubs.

The UK, and London specifically, remains the deepest market for late-stage capital in Europe. The concentration of dedicated growth funds, crossover investors, and international capital — particularly from the US and Middle East — means that UK-headquartered companies can often access larger rounds at more competitive valuations than equivalent businesses elsewhere in Europe. The London market also has greater familiarity with complex deal structures and a more developed ecosystem of advisors and investment banks that specialize in growth-stage transactions.

The DACH region, particularly Germany, has produced a consistent pipeline of late-stage companies in fintech, industrial software, and e-commerce. Munich and Berlin have attracted a number of dedicated growth funds, and German companies have increasingly been able to raise substantial rounds domestically, though US and pan-European funds still play an important role. Swiss-headquartered companies, particularly in life sciences and deep tech, benefit from proximity to both European and US institutional capital.

The Nordic countries — Sweden, Finland, Denmark, and Norway — punch above their weight in growth-stage activity relative to population. Stockholm in particular has a mature ecosystem with strong local growth investors and a culture of capital efficiency that has produced companies with attractive unit economics. Nordic founders tend to run efficient processes and are generally sophisticated about investor selection.

Southern Europe, including Spain, Portugal, and Italy, has seen meaningful growth in late-stage activity, though round sizes remain generally smaller and the local institutional growth capital base is thinner. Cross-border fundraising from pan-European or US funds is more important in these markets.

Eastern Europe, including Poland, Romania, and the Baltic states, is earlier in its development of late-stage infrastructure. Companies from these markets that reach growth stage often relocate their headquarters or primary investor relationships to Western European hubs to access deeper capital pools.

Other funding stages

Browse by investor type